Linezolid resistance in a clinical isolate of Staphylococcus aureus.
about
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaFuture challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSALinezolid versus vancomycin for skin and soft tissue infectionsLinezolid versus vancomycin for skin and soft tissue infectionsDetermining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release.Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophesReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsActivity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolidThe oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioningR chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistanceGenome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistanceLinezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistancesIn vitro activities of the Rx-01 oxazolidinones against hospital and community pathogensAntimicrobial resistance: the example of Staphylococcus aureusBench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumoniaCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciPotential role of tedizolid phosphate in the treatment of acute bacterial skin infectionsAntibiotics that target protein synthesisStructural features and kinetic characterization of alanine racemase fromStaphylococcus aureus(Mu50)Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient populationNovel bacterial metabolite merochlorin A demonstrates in vitro activity against multi-drug resistant methicillin-resistant Staphylococcus aureusTranscriptional profiles of the response of methicillin-resistant Staphylococcus aureus to pentacyclic triterpenoidsRoemerine Improves the Survival Rate of Septicemic BALB/c Mice by Increasing the Cell Membrane Permeability of Staphylococcus aureusBad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of AmericaIdentification and characterization of the multidrug resistance gene cfr in a Panton-Valentine leukocidin-positive sequence type 8 methicillin-resistant Staphylococcus aureus IVa (USA300) isolate.Potential novel antibiotics from HTS targeting the virulence-regulating transcription factor, VirF, from Shigella flexneri.Identification of potential targets in Staphylococcus aureus N315 using computer aided protein data analysis.An array of target-specific screening strains for antibacterial discovery.Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs.Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.A review of linezolid: the first oxazolidinone antibiotic.Linezolid versus vancomycin for skin and soft tissue infections.Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureusEmergence of linezolid resistance in a clinical Staphylococcus capitis isolate from Jiangsu Province of China in 2012.A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in Staphylococcus aureusIdentification, cloning, and functional characterization of EmrD-3, a putative multidrug efflux pump of the major facilitator superfamily from Vibrio cholerae O395Polyphyletic emergence of linezolid-resistant staphylococci in the United StatesMechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing.Structural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome.
P2860
Q22241905-B7F411BB-B1CB-49C4-937A-8422A242415FQ22305769-CE8B68BB-CC25-453B-95A8-444DFD37A71AQ24186563-E640738F-58A4-40F7-891D-89ED496ECB66Q24201228-B49A6EB3-B37F-4412-B776-7A0CBD4B96F1Q24535971-33B85AAF-6B82-4F48-97BA-5874E5B03DA2Q24564447-EBF74B72-FB9A-494E-B1B3-4609DB7AFF3DQ24646677-9AFEE837-5DD1-425D-BB60-5AB58C739922Q24650535-C1F6D611-6738-4D49-AC86-7B46864F8D98Q24652742-9899762B-998B-4565-B77D-4982CB355F51Q24653939-81B93098-2365-4681-86E2-90A981B6BF6FQ24655140-6438CCED-7616-44E4-A792-F6125E0E4C48Q24655996-8EDEF512-1C4E-4433-A916-9792020C95FBQ24656140-29921253-536E-47EB-AB26-3206296B4177Q24676363-743DFB8E-BB42-485C-B796-95328C902D24Q24811492-75AEAD3E-703E-46F8-AE44-247093D3755BQ26853465-7592D451-9368-43F1-A1C8-9669C451E7F0Q26853612-33A4C584-BA4C-4FD5-A9CD-31A5F035BA80Q27025271-E622761E-BC43-47B1-8E30-BF3D7815D3E3Q27676379-04CA6959-8AD0-43B1-B104-9E8A8095CA2EQ28182298-7384094F-9071-4EE7-A78B-C1E2B08E630DQ28478951-2FE6A411-1A58-48B4-9AC8-5ECAB9FE1A93Q28486248-937E17FA-F8E1-4AD5-84A4-7AC4C3BEE292Q28551167-558AAB16-E48E-4246-9AF3-09EB4C5201F1Q29616084-DD1A83F9-9F91-46EA-A6A2-66572DEFEC4FQ30394525-080DC584-D00F-4967-A3B9-A21D3955E8A3Q30580404-4AB72411-6C57-4135-B6DF-BD46E9E27DF7Q30605140-1232A270-267A-4B2B-8900-E022C3C1730BQ30834642-546A61F9-8243-495A-A760-58E92AFF9A26Q33245188-377B84BC-ECB4-4518-8375-2E995A7E6DA2Q33264579-DE693220-A4AC-4908-AE53-3FC4D3D9705DQ33363226-9F498D6F-E151-4B63-BDCD-638CCE2DA675Q33418740-91131D30-FA6F-4D2C-BD73-53A11FFC8749Q33525230-525F92D1-4191-408A-87B8-9577ECE7C558Q33556476-CCF0F71F-4EA0-43BF-A6FB-EEC7CA43167BQ33586058-EC9B8039-DFB4-41FA-8717-308AF805D17BQ33600086-A5F8EA7C-65E6-4AAF-8D61-4E22648799DEQ33603996-82E4B7AB-F2BC-400C-8D18-09C99D8316B9Q33613747-EE16A19C-2A7D-4B53-9BF1-A41FBA19EA7BQ33648052-59AEB66D-49C2-41E4-B45F-12C27C78ACD3Q33654525-B524092A-E592-4D68-BD68-81514ED38FC9
P2860
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
@en
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
@nl
type
label
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
@en
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
@nl
prefLabel
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
@en
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
@nl
P2093
P1433
P1476
Linezolid resistance in a clinical isolate of Staphylococcus aureus.
@en
P2093
C Wennersten
G M Eliopoulos
G Sakoulas
L Venkataraman
M J Ferraro
R C Moellering
P304
P356
10.1016/S0140-6736(01)05410-1
P407
P577
2001-07-01T00:00:00Z